Siglec-15

Siglec-15 詳細

英語名Sialic acid-binding Ig-like lectin 15市販薬剤の数0
治験薬の数3ターゲットの別称SIGLEC15,Sialic Acid Binding Ig Like Lectin 15,CD33 Antigen-Like 3,CD33L3,Sialic Acid-Binding Ig-Like Lectin 15,SIGLEC-15,HsT1361,CD33 Molecule-Like 3,Sialic Acid Binding Ig-Like Lectin 15
研究&開発段階Phase 2 Clinical
英語名Sialic acid-binding Ig-like lectin 15
ターゲットの別称SIGLEC15,Sialic Acid Binding Ig Like Lectin 15,CD33 Antigen-Like 3,CD33L3,Sialic Acid-Binding Ig-Like Lectin 15,SIGLEC-15,HsT1361,CD33 Molecule-Like 3,Sialic Acid Binding Ig-Like Lectin 15
市販薬剤の数0
治験薬の数3
研究&開発段階Phase 2 Clinical

Siglec-15 製品リスト

  • 属性

    Protein (7)

  • 製品ライブラリ

    オンライン (7)

  • Human (4)Rhesus macaque (1)Mouse (1)Rat (1)

  • タグ

    Fc Tag (1)His Tag (4)His Tag & Avi Tag (1)Fc Tag & Avi Tag (1)

  • マーカー

    Unconjugated (5)Biotin-labeled (2)

Siglec-15バックグランド

Siglec-15 is a DAP12-associated immunoreceptor, which belongs to the immunoglobulin superfamily and SIGLEC (sialic acid binding Ig-like lectin) family. Siglecs are cell surface proteins that bind sialic acid. They are found primarily on the surface of immune cells and are a subset of the I-type lectins. Siglec-15 consisting of immunoglobulin (Ig)-like domains, transmembrane domain and a short cytoplasmic tail. Siglec-15 is that recognizes sialylated glycans and regulates osteoclast differentiation. Siglec-15 is a potential therapeutic target for osteoporosis and plays a conserved regulatory role in the immune system of vertebrates.

Siglec-15分子の別称

CD33 antigen-like 3,SIGLEC-15,CD33L3,sialic acid-binding Ig-like lectin 15,Siglec15,Siglec-15

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
NC-318NC-318; 5G-12Phase 2 ClinicalYale School Of MedicineBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Endometrial Neoplasms; Lung Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
DS-1501DS-1501Phase 1 ClinicalDaiichi Sankyo Co LtdOsteoporosis
詳細
BSI-060TPYX-106; BSI-060TPhase 1 ClinicalBiosion IncNeoplasm Metastasis; Solid tumours
詳細

レビュー

  • 1***22019-10-11
    6評価
    Siglec-15 is a relatively new type of immune checkpoint molecule. In the process of antibody molecule screening, we used ACRO's Siglec-15 antigen. It has shown very good stability in protein-level binding experiments, and the bioactivity was also quite good which was verified in functional experiments.
  • 1***32019-10-11
    1評価
    The product is pretty good and the price is competitive. Besides, the delivery was fast. In particular, there is a literature introduction cited the product. It is obvious that each target has been carefully studied.
  • 1***22019-10-12
    8評価
    We can obtain a good inhibitory effect using this protein to verify its inhibitory on T-cells functions. S15-hFc protein can effectively inhibit the secretion of IFN-gamma stimulated by OKT3 in CD4 + T cells.
  • 詳細
  • 製品リスト
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8